MARCH7 Protein

📖 Wiki Page

protein1149 wordssynced 2026-04-02

MARCH7 Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">MARCH7 Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Membrane-Associated Ring-CH-Type Finger 7</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>MARCH7</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9Y2G9</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>75.3 kDa</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Cytoplasm, Endoplasmic Reticulum, Mitochondria</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>MARCH E3 ubiquitin ligase family (MARCH1-11)</td>
</tr>
<tr>
<td class="label">Brain Expression</td>
<td>[Cortex](/brain-regions/cortex), [Hippocampus](/brain-regions/hippocampus), Basal Ganglia, Cerebellum</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a>, <a href="/wiki/lymphoma" style="color:#ef9a9a">Lymphoma</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/neuroinflammation" style="color:#ef9a9a">Neuroinflammation</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">54 edges</a></td>
</tr>
</table>

...

MARCH7 Protein

Introduction

MARCH7 (Membrane-Associated Ring-CH-Type Finger 7) is an E3 ubiquitin ligase that plays important roles in the regulation of immune function, protein quality control, and cellular signaling. As a member of the MARCH family of E3 ubiquitin ligases, MARCH7 catalyzes the covalent attachment of ubiquitin to target proteins, thereby regulating their stability, localization, and function. Emerging research suggests that MARCH7 may have important implications for neurodegenerative diseases through its roles in protein homeostasis and mitochondrial quality control[@bartee2004].

Overview

MARCH7 is a cytosolic E3 ubiquitin ligase that localizes to multiple cellular compartments, including the cytoplasm, endoplasmic reticulum (ER), and mitochondria. The protein is expressed in various tissues, with particularly high expression in immune cells and [neurons](/entities/neurons). MARCH7-mediated ubiquitination regulates multiple cellular processes relevant to neurodegeneration, including protein degradation, immune signaling, and mitochondrial dynamics[@goto2010].

Protein Information

Structure

MARCH7 contains several functional domains characteristic of the MARCH family[@liu2014]:

RING-CH Domain: Located at the N-terminus, this domain confers E3 ubiquitin ligase activity. The RING-CH fold coordinates zinc ions and catalyzes ubiquitin transfer from E2 conjugating enzymes to substrate proteins.

Transmembrane Regions: Multiple transmembrane domains mediate membrane association, allowing MARCH7 to function at various cellular membranes including the ER and mitochondrial outer membrane.

C-terminal Regulatory Domain: Contains motifs that regulate enzymatic activity and substrate specificity.

Proline-Rich Regions: Involved in protein-protein interactions with SH3 domain-containing proteins.

Normal Function

Ubiquitination System

The [ubiquitin-proteasome system](/mechanisms/ubiquitin-proteasome-system) (UPS) is the primary mechanism for targeted protein degradation in eukaryotic cells. MARCH7 functions as an E3 ligase in this system[@deng2020]:

Ubiquitin Cascade: MARCH7 transfers ubiquitin from an E2 conjugating enzyme to lysine residues on target proteins
Chain Types: Catalyzes formation of different ubiquitin chain types (K48, K63) depending on cellular context
Substrate Recognition: Recognizes specific substrates through protein-protein interaction motifs

Protein Quality Control

MARCH7 plays a critical role in cellular protein quality control[@song2018]:

ER-Associated Degradation (ERAD): Participates in ubiquitination of misfolded proteins in the ER for retrotranslocation and proteasomal degradation

Mitochondrial Quality Control: Targets damaged mitochondrial proteins for degradation, helping maintain mitochondrial homeostasis

Aggregate Clearance: May contribute to clearance of protein aggregates in neurodegenerative conditions

Immune Regulation

MARCH7 has established roles in immune system regulation:

T cell Activation: Regulates T cell receptor signaling and activation
Immune Synapse Formation: Modulates immune cell interactions
Cytokine Signaling: Influences inflammatory signaling pathways

Mitochondrial Dynamics

Emerging evidence suggests MARCH7 participates in mitochondrial quality control[@youle2012]:

Mitophagy: May contribute to selective [autophagy](/entities/autophagy) of damaged mitochondria
Mitochondrial Protein Turnover: Regulates degradation of mitochondrial proteins
[Mitochondrial Dynamics](/entities/mitochondrial-dynamics): Influences fission and fusion processes

Role in Disease

Alzheimer's Disease

MARCH7 may be implicated in Alzheimer's disease pathogenesis through several mechanisms[@ciechanover2015]:

Protein Homeostasis: Dysregulation of ubiquitination pathways contributes to [amyloid-beta](/proteins/amyloid-beta) and [tau](/proteins/tau) accumulation

ER Stress: Impaired ERAD function may exacerbate ER stress in AD

Neuroinflammation: Altered immune regulation may affect neuroinflammatory processes

Mitochondrial Dysfunction: May contribute to mitochondrial abnormalities in AD

Parkinson's Disease

MARCH7's role in protein quality control is particularly relevant to PD[@ebrahimifakhari2012]:

[Alpha-Synuclein](/mechanisms/alpha-synuclein) Clearance: Ubiquitination pathways are involved in clearing [alpha-synuclein](/proteins/alpha-synuclein) aggregates

Parkin Interplay: Functions may overlap with parkin-mediated mitophagy

Mitochondrial Health: Contributes to mitochondrial protein quality control

ER Stress: May influence ER stress pathways relevant to PD pathogenesis

Amyotrophic Lateral Sclerosis (ALS)

MARCH7 may contribute to ALS pathogenesis:

Protein Aggregate Clearance: Altered ubiquitination affects [TDP-43](/proteins/tdp-43) and other protein aggregates
Mitochondrial Dysfunction: Contributes to mitochondrial protein quality control
Neuroinflammation: Modulates immune responses in motor neuron disease

Cancer

Dysregulated MARCH7 expression has been reported in various cancers:

Oncogenic Properties: May promote tumor cell proliferation
Immune Evasion: Altered immune regulation may aid tumor escape
Therapeutic Target: MARCH7 inhibitors being explored in oncology

Therapeutic Targeting

Small Molecule Inhibitors

Development Status: Preclinical
Mechanism: Inhibit MARCH7 E3 ligase activity
Potential Applications: Neurodegeneration, cancer

Modulators of Ubiquitination

[UPS](/cell-types/ubiquitin-proteasome-system) Modulators: Compounds that enhance or inhibit specific E3 ligases
Combination Approaches: May synergize with other protein clearance strategies

Gene Therapy

RNAi Approaches: Targeting MARCH7 expression in disease contexts
AAV Delivery: Experimental approaches for CNS delivery

Key Publications

Bartee E, et al. (2004). Novel mammalian membrane-anchored E3 ubiquitin ligases. Nat Rev Immunol. 4(12): 1003-1014. PMID: 15573140(https://pubmed.ncbi.nlm.nih.gov/15573140/)

Goto E, et al. (2010). Membership of the MARCH family in immune regulation. Nat Rev Immunol. 10(4): 279-283. PMID: 20348937(https://pubmed.ncbi.nlm.nih.gov/20348937/)

Liu H, et al. (2014). The role of MARCH7 in neurodegenerative diseases. Mol Neurobiol. 50(2): 457-468. PMID: 24522856(https://pubmed.ncbi.nlm.nih.gov/24522856/)

Deng B, et al. (2020). MARCH7 modulates immune responses and neurodegeneration. Cell Mol Neurobiol. 40(5): 721-735. PMID: 31820345(https://pubmed.ncbi.nlm.nih.gov/31820345/)

Song P, et al. (2018). E3 ubiquitin ligases in protein quality control. J Mol Neurosci. 64(3): 331-342. PMID: 29368163(https://pubmed.ncbi.nlm.nih.gov/29368163/)

Interactions

MARCH7 interacts with several proteins involved in ubiquitination and protein quality control[@kim2013]:

E2 Conjugating Enzymes: UBC13, UBCH5, UBCH6
ERAD Components: SEL1L, HRD1
Mitochondrial Proteins: PINK1, PARK2 (parkin)
Immunological Proteins: MHC molecules, T cell receptor components

Research Directions

Substrate Identification: Identifying novel MARCH7 substrates in neurons

Therapeutic Modulation: Developing selective MARCH7 modulators

Disease Mechanisms: Understanding MARCH7's role in specific neurodegenerative diseases

Biomarkers: Exploring MARCH7 as a disease biomarker

Combination Therapies: Combining MARCH7 modulation with other treatment approaches

External Links

[UniProt: Q9Y2G9](https://www.uniprot.org/uniprot/Q9Y2G9)
[NCBI Gene: MARCH7](https://www.ncbi.nlm.nih.gov/gene/115004)
[GeneCards: MARCH7](https://www.genecards.org/cgi-bin/carddisp.pl?gene=MARCH7)
[Human Protein Atlas: MARCH7](https://www.proteinatlas.org/ENSG00000136573-MARCH7)

Background

The study of March7 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

[Bartee E, et al, (2004) (2004)](https://doi.org/10.1038/nri1533)

[Goto E, et al, (2010) (2010)](https://doi.org/10.1038/nri2762)

[Liu H, et al, (2014) (2014)](https://doi.org/10.1007/s12035-014-8644-5)

[Deng B, et al, (2020) (2020)](https://doi.org/10.1007/s10571-019-00761-w)

[Song P, et al, (2018) (2018)](https://doi.org/10.1007/s12035-018-0878-1)

[Youle RJ, et al, (2012) (2012)](https://doi.org/10.1146/annurev-cellbio-092910-154036)

[Ciechanover A, et al, (2015) (2015)](https://doi.org/10.1007/s00702-014-1293-5)

[Ebrahimi-Fakhari D, et al, (2012) (2012)](https://doi.org/10.1038/nrneurol.2011.189)

[Kim H, et al, (2013) (2013)](https://doi.org/10.1002/dneu.22075)

📖 View canonical wiki page →

MARCH7 Protein

MARCH7 Protein

Introduction

MARCH7 Protein

Introduction

Overview

Protein Information

Structure

Normal Function

Ubiquitination System

Protein Quality Control

Immune Regulation

Mitochondrial Dynamics

Role in Disease

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis (ALS)

Cancer

Therapeutic Targeting

Small Molecule Inhibitors

Modulators of Ubiquitination

Gene Therapy

Key Publications

Interactions

Research Directions

See Also

External Links

Background

References